Where does Genomic Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genomic Health, Inc. ranks #14,639 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genomic Health, Inc. hold?

Genomic Health, Inc. holds 20 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Genomic Health, Inc.'s Innovation Score?

Genomic Health, Inc. has an Innovation Score of 34.8 out of 100 (top 51% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Genomic Health, Inc.'s patent grant rate increasing or decreasing?

Genomic Health, Inc.'s recent grant velocity is -10% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Genomic Health, Inc.'s patents?

Genomic Health, Inc.'s patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genomic Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Genomic Health, Inc.

Q: What technology areas does Genomic Health, Inc. focus on?

Genomic Health, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 20 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genomic ranks #14,639 of 50,000 tracked US assignees by granted-patent volume, with 20 patents across 10 technology areas.

#14,639
of 50,000 US assignees by volume: Top 51%
by Innovation Score (34.8/100): 15.7
avg claims per patent: -10%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14639 · US Corporation #14,639 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,639/50,000
PHOTO-FINISH Ganeden Biotech
CPC-FOCUS C12Q · 10 areas
INNOV-THIN 34.8/100
CLAIMS-RICH 15.7 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -10% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ganeden Biotech, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Genomic Health · this assignee

35
3D Lighting Innovati… · lowest

7

What this shows Genomic Health, Inc. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-FLAT, BOOK-FULL. Volume places it #14,639 of 50,000; Innovation Score 34.8/100 sits in the top 51% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Ganeden Biotech, Inc. (±0 grants).

Portfolio overview

Genomic Health, Inc. has been granted 20 US utility patents between 2015 and 2025, placing Genomic Health, Inc. at #14,639 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Genomic Health, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Genomic sits between Guangdong Welling Motor Manufacturing Co., Ltd. (20 patents, rank #14,642) and Glycosyn Llc (20 patents, rank #14,650) - the closest US assignees by grant volume. The composite Innovation Score of 34.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 9 grants, compared with 10 in the 2015–2019 window, a -10% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Genomic Health, Inc.'s 15.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 10 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Guangdong Welling…

20
Guangzhou Alpha C…

20
Ganeden Biotech

20
Genesis

20
Genpact Luxembour…

20
Geobrugg

20
Giesecke+Devrient…

20
Glycosyn

20
Genomic Health ◀

20

What this shows Genomic holds 20 patents at rank #14,646, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genomic

By rank, the assignees closest to #14,646 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Genomic's primary technology class.

Genomic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 51% higher than 49% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genomic Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2017	2	10.0%
2018	2	10.0%
2019	5	25.0%
2020	1	5.0%
2021	3	15.0%
2022	1	5.0%
2023	4	20.0%
2025partial year	1	5.0%

Which technologies does Genomic Health, Inc. patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 20

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 9

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 8

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 4

G16Z - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR 3

G16C - COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#14,639

of 50,000 tracked assignees

Innovation Score

34.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.